ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GLP-1 Weight Loss Pill Market Research Report 2026
Published Date: 2026-01-19
|
Report Code: QYRE-Auto-12O18755
Home | Market Reports | Health| Pharmacy
Global GLP 1 Weight Loss Pill Market Research Report 2024
BUY CHAPTERS

Global GLP-1 Weight Loss Pill Market Research Report 2026

Code: QYRE-Auto-12O18755
Report
2026-01-19
Pages:130
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Reddy's Laboratories
Merck
Huadong Medicine
Borui Pharmaceuticals
Hengrui Medicine
Innovent Biologics
Hansoh Pharmaceuticals
Gan & Lee Pharmaceuticals
CSPC Pharmaceuticals
Wanbang Biopharma
IMEIK
Aurisco Pharmaceuticals
Shanghai Benemae Biopharmaceuticals Co., Ltd.
Sihuan Pharmaceuticals
Gan & Lee Pharmaceuticals

GLP-1 Weight Loss Pill Market Size

The global GLP-1 Weight Loss Pill market was valued at US$ 1472 million in 2025 and is anticipated to reach US$ 2960 million by 2032, at a CAGR of 10.7% from 2026 to 2032.

GLP-1 Weight Loss Pill Market

GLP-1 Weight Loss Pill Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on GLP-1 Weight Loss Pill competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
GLP-1 (glucagon-like peptide-1) weight loss drugs are a class of drugs developed based on GLP-1 or its analogs, which are designed to help lose weight by simulating or enhancing the physiological effects of GLP-1. GLP-1 weight loss drugs usually act as GLP-1 receptor agonists. They can bind to GLP-1 receptors in the body, thereby activating the receptors and triggering a series of biological effects. GLP-1 weight loss drugs can suppress appetite, slow gastric emptying, and promote fat metabolism. At present, there are many GLP-1 weight loss drugs on the market, such as liraglutide, benaglutide, semaglutide and Tirzepatide.
The North American market for GLP-1 Weight Loss Pill is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for GLP-1 Weight Loss Pill is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of GLP-1 Weight Loss Pill include Novo Nordisk, Eli Lilly, Reddy's Laboratories, Merck, Aurisco Pharmaceuticals, Huadong Medicine, Borui Pharmaceuticals, Hengrui Medicine, Innovent Biologics, Shanghai Benemae Biopharmaceuticals Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global GLP-1 Weight Loss Pill market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding GLP-1 Weight Loss Pill. The GLP-1 Weight Loss Pill market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global GLP-1 Weight Loss Pill market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist GLP-1 Weight Loss Pill manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of GLP-1 Weight Loss Pill Market Report

Report Metric Details
Report Name GLP-1 Weight Loss Pill Market
Accounted market size in 2025 US$ 1472 in million
Forecasted market size in 2032 US$ 2960 million
CAGR 10.7%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Oral
  • Injection
by Application
  • Hospital
  • Pharmacy
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, Eli Lilly, Reddy's Laboratories, Merck, Aurisco Pharmaceuticals, Huadong Medicine, Borui Pharmaceuticals, Hengrui Medicine, Innovent Biologics, Shanghai Benemae Biopharmaceuticals Co., Ltd., Hansoh Pharmaceuticals, Gan & Lee Pharmaceuticals, CSPC Pharmaceuticals, Wanbang Biopharma, Sihuan Pharmaceuticals, Imeik
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for GLP-1 Weight Loss Pill manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines GLP-1 Weight Loss Pill sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is GLP-1 Weight Loss Pill Market growing?

Ans: The GLP-1 Weight Loss Pill Market witnessing a CAGR of 10.7% during the forecast period 2026-2032.

What is the GLP-1 Weight Loss Pill Market size in 2032?

Ans: The GLP-1 Weight Loss Pill Market size in 2032 will be US$ 2960 million.

Who are the main players in the GLP-1 Weight Loss Pill Market report?

Ans: The main players in the GLP-1 Weight Loss Pill Market are Novo Nordisk, Eli Lilly, Reddy's Laboratories, Merck, Aurisco Pharmaceuticals, Huadong Medicine, Borui Pharmaceuticals, Hengrui Medicine, Innovent Biologics, Shanghai Benemae Biopharmaceuticals Co., Ltd., Hansoh Pharmaceuticals, Gan & Lee Pharmaceuticals, CSPC Pharmaceuticals, Wanbang Biopharma, Sihuan Pharmaceuticals, Imeik

What are the Application segmentation covered in the GLP-1 Weight Loss Pill Market report?

Ans: The Applications covered in the GLP-1 Weight Loss Pill Market report are Hospital, Pharmacy, Clinic, Others

What are the Type segmentation covered in the GLP-1 Weight Loss Pill Market report?

Ans: The Types covered in the GLP-1 Weight Loss Pill Market report are Oral, Injection

1 GLP-1 Weight Loss Pill Market Overview
1.1 Product Definition
1.2 GLP-1 Weight Loss Pill by Type
1.2.1 Global GLP-1 Weight Loss Pill Market Value by Type: 2025 vs 2032
1.2.2 Oral
1.2.3 Injection
1.3 GLP-1 Weight Loss Pill by Application
1.3.1 Global GLP-1 Weight Loss Pill Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinic
1.3.5 Others
1.4 Global GLP-1 Weight Loss Pill Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Weight Loss Pill Revenue 2021–2032
1.4.2 Global GLP-1 Weight Loss Pill Sales 2021–2032
1.4.3 Global GLP-1 Weight Loss Pill Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 GLP-1 Weight Loss Pill Market Competition by Manufacturers
2.1 Global GLP-1 Weight Loss Pill Sales Market Share by Manufacturers (2021–2026)
2.2 Global GLP-1 Weight Loss Pill Revenue Market Share by Manufacturers (2021–2026)
2.3 Global GLP-1 Weight Loss Pill Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of GLP-1 Weight Loss Pill, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of GLP-1 Weight Loss Pill, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of GLP-1 Weight Loss Pill, Product Types and Applications
2.7 Global Key Manufacturers of GLP-1 Weight Loss Pill, Date of Entry into the Industry
2.8 Global GLP-1 Weight Loss Pill Market Competitive Situation and Trends
2.8.1 Global GLP-1 Weight Loss Pill Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global GLP-1 Weight Loss Pill Players Market Share by Revenue
2.8.3 Global GLP-1 Weight Loss Pill Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Weight Loss Pill Market Scenario by Region
3.1 Global GLP-1 Weight Loss Pill Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global GLP-1 Weight Loss Pill Sales by Region: 2021–2032
3.2.1 Global GLP-1 Weight Loss Pill Sales by Region: 2021–2026
3.2.2 Global GLP-1 Weight Loss Pill Sales by Region: 2027–2032
3.3 Global GLP-1 Weight Loss Pill Revenue by Region: 2021–2032
3.3.1 Global GLP-1 Weight Loss Pill Revenue by Region: 2021–2026
3.3.2 Global GLP-1 Weight Loss Pill Revenue by Region: 2027–2032
3.4 North America GLP-1 Weight Loss Pill Market Facts & Figures by Country
3.4.1 North America GLP-1 Weight Loss Pill Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America GLP-1 Weight Loss Pill Sales by Country (2021–2032)
3.4.3 North America GLP-1 Weight Loss Pill Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Weight Loss Pill Market Facts & Figures by Country
3.5.1 Europe GLP-1 Weight Loss Pill Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe GLP-1 Weight Loss Pill Sales by Country (2021–2032)
3.5.3 Europe GLP-1 Weight Loss Pill Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Weight Loss Pill Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Weight Loss Pill Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific GLP-1 Weight Loss Pill Sales by Region (2021–2032)
3.6.3 Asia Pacific GLP-1 Weight Loss Pill Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Weight Loss Pill Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Weight Loss Pill Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America GLP-1 Weight Loss Pill Sales by Country (2021–2032)
3.7.3 Latin America GLP-1 Weight Loss Pill Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Weight Loss Pill Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Weight Loss Pill Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa GLP-1 Weight Loss Pill Sales by Country (2021–2032)
3.8.3 Middle East and Africa GLP-1 Weight Loss Pill Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Weight Loss Pill Sales by Type (2021–2032)
4.1.1 Global GLP-1 Weight Loss Pill Sales by Type (2021–2026)
4.1.2 Global GLP-1 Weight Loss Pill Sales by Type (2027–2032)
4.1.3 Global GLP-1 Weight Loss Pill Sales Market Share by Type (2021–2032)
4.2 Global GLP-1 Weight Loss Pill Revenue by Type (2021–2032)
4.2.1 Global GLP-1 Weight Loss Pill Revenue by Type (2021–2026)
4.2.2 Global GLP-1 Weight Loss Pill Revenue by Type (2027–2032)
4.2.3 Global GLP-1 Weight Loss Pill Revenue Market Share by Type (2021–2032)
4.3 Global GLP-1 Weight Loss Pill Price by Type (2021–2032)
5 Segment by Application
5.1 Global GLP-1 Weight Loss Pill Sales by Application (2021–2032)
5.1.1 Global GLP-1 Weight Loss Pill Sales by Application (2021–2026)
5.1.2 Global GLP-1 Weight Loss Pill Sales by Application (2027–2032)
5.1.3 Global GLP-1 Weight Loss Pill Sales Market Share by Application (2021–2032)
5.2 Global GLP-1 Weight Loss Pill Revenue by Application (2021–2032)
5.2.1 Global GLP-1 Weight Loss Pill Revenue by Application (2021–2026)
5.2.2 Global GLP-1 Weight Loss Pill Revenue by Application (2027–2032)
5.2.3 Global GLP-1 Weight Loss Pill Revenue Market Share by Application (2021–2032)
5.3 Global GLP-1 Weight Loss Pill Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novo Nordisk GLP-1 Weight Loss Pill Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Eli Lilly GLP-1 Weight Loss Pill Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Reddy's Laboratories
6.3.1 Reddy's Laboratories Company Information
6.3.2 Reddy's Laboratories Description and Business Overview
6.3.3 Reddy's Laboratories GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Reddy's Laboratories GLP-1 Weight Loss Pill Product Portfolio
6.3.5 Reddy's Laboratories Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Merck GLP-1 Weight Loss Pill Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Aurisco Pharmaceuticals
6.5.1 Aurisco Pharmaceuticals Company Information
6.5.2 Aurisco Pharmaceuticals Description and Business Overview
6.5.3 Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.5.5 Aurisco Pharmaceuticals Recent Developments/Updates
6.6 Huadong Medicine
6.6.1 Huadong Medicine Company Information
6.6.2 Huadong Medicine Description and Business Overview
6.6.3 Huadong Medicine GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Huadong Medicine GLP-1 Weight Loss Pill Product Portfolio
6.6.5 Huadong Medicine Recent Developments/Updates
6.7 Borui Pharmaceuticals
6.7.1 Borui Pharmaceuticals Company Information
6.7.2 Borui Pharmaceuticals Description and Business Overview
6.7.3 Borui Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Borui Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.7.5 Borui Pharmaceuticals Recent Developments/Updates
6.8 Hengrui Medicine
6.8.1 Hengrui Medicine Company Information
6.8.2 Hengrui Medicine Description and Business Overview
6.8.3 Hengrui Medicine GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hengrui Medicine GLP-1 Weight Loss Pill Product Portfolio
6.8.5 Hengrui Medicine Recent Developments/Updates
6.9 Innovent Biologics
6.9.1 Innovent Biologics Company Information
6.9.2 Innovent Biologics Description and Business Overview
6.9.3 Innovent Biologics GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Innovent Biologics GLP-1 Weight Loss Pill Product Portfolio
6.9.5 Innovent Biologics Recent Developments/Updates
6.10 Shanghai Benemae Biopharmaceuticals Co., Ltd.
6.10.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
6.10.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. Description and Business Overview
6.10.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Product Portfolio
6.10.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments/Updates
6.11 Hansoh Pharmaceuticals
6.11.1 Hansoh Pharmaceuticals Company Information
6.11.2 Hansoh Pharmaceuticals Description and Business Overview
6.11.3 Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.11.5 Hansoh Pharmaceuticals Recent Developments/Updates
6.12 Gan & Lee Pharmaceuticals
6.12.1 Gan & Lee Pharmaceuticals Company Information
6.12.2 Gan & Lee Pharmaceuticals Description and Business Overview
6.12.3 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.12.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
6.13 CSPC Pharmaceuticals
6.13.1 CSPC Pharmaceuticals Company Information
6.13.2 CSPC Pharmaceuticals Description and Business Overview
6.13.3 CSPC Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 CSPC Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.13.5 CSPC Pharmaceuticals Recent Developments/Updates
6.14 Wanbang Biopharma
6.14.1 Wanbang Biopharma Company Information
6.14.2 Wanbang Biopharma Description and Business Overview
6.14.3 Wanbang Biopharma GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Wanbang Biopharma GLP-1 Weight Loss Pill Product Portfolio
6.14.5 Wanbang Biopharma Recent Developments/Updates
6.15 Sihuan Pharmaceuticals
6.15.1 Sihuan Pharmaceuticals Company Information
6.15.2 Sihuan Pharmaceuticals Description and Business Overview
6.15.3 Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
6.15.5 Sihuan Pharmaceuticals Recent Developments/Updates
6.16 Imeik
6.16.1 Imeik Company Information
6.16.2 Imeik Description and Business Overview
6.16.3 Imeik GLP-1 Weight Loss Pill Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Imeik GLP-1 Weight Loss Pill Product Portfolio
6.16.5 Imeik Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Weight Loss Pill Industry Chain Analysis
7.2 GLP-1 Weight Loss Pill Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Weight Loss Pill Production Mode & Process Analysis
7.4 GLP-1 Weight Loss Pill Sales and Marketing
7.4.1 GLP-1 Weight Loss Pill Sales Channels
7.4.2 GLP-1 Weight Loss Pill Distributors
7.5 GLP-1 Weight Loss Pill Customer Analysis
8 GLP-1 Weight Loss Pill Market Dynamics
8.1 GLP-1 Weight Loss Pill Industry Trends
8.2 GLP-1 Weight Loss Pill Market Drivers
8.3 GLP-1 Weight Loss Pill Market Challenges
8.4 GLP-1 Weight Loss Pill Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Reddy's Laboratories
Merck
Huadong Medicine
Borui Pharmaceuticals
Hengrui Medicine
Innovent Biologics
Hansoh Pharmaceuticals
Gan & Lee Pharmaceuticals
CSPC Pharmaceuticals
Wanbang Biopharma
IMEIK
Aurisco Pharmaceuticals
Shanghai Benemae Biopharmaceuticals Co., Ltd.
Sihuan Pharmaceuticals
Gan & Lee Pharmaceuticals
List of Tables
 Table 1. Global GLP-1 Weight Loss Pill Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global GLP-1 Weight Loss Pill Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global GLP-1 Weight Loss Pill Market Competitive Situation by Manufacturers in 2025
 Table 4. Global GLP-1 Weight Loss Pill Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global GLP-1 Weight Loss Pill Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global GLP-1 Weight Loss Pill Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global GLP-1 Weight Loss Pill Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market GLP-1 Weight Loss Pill Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of GLP-1 Weight Loss Pill, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of GLP-1 Weight Loss Pill, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of GLP-1 Weight Loss Pill, Product Types and Applications
 Table 12. Global Key Manufacturers of GLP-1 Weight Loss Pill, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GLP-1 Weight Loss Pill Companies by Tier (Tier 1, Tier 2, Tier 3), based on GLP-1 Weight Loss Pill Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GLP-1 Weight Loss Pill Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global GLP-1 Weight Loss Pill Sales by Region (K Units), 2021–2026
 Table 18. Global GLP-1 Weight Loss Pill Sales Market Share by Region (2021–2026)
 Table 19. Global GLP-1 Weight Loss Pill Sales by Region (K Units), 2027–2032
 Table 20. Global GLP-1 Weight Loss Pill Sales Market Share by Region (2027–2032)
 Table 21. Global GLP-1 Weight Loss Pill Revenue by Region (US$ Million), 2021–2026
 Table 22. Global GLP-1 Weight Loss Pill Revenue Market Share by Region (2021–2026)
 Table 23. Global GLP-1 Weight Loss Pill Revenue by Region (US$ Million), 2027–2032
 Table 24. Global GLP-1 Weight Loss Pill Revenue Market Share by Region (2027–2032)
 Table 25. North America GLP-1 Weight Loss Pill Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America GLP-1 Weight Loss Pill Sales by Country (K Units), 2021–2026
 Table 27. North America GLP-1 Weight Loss Pill Sales by Country (K Units), 2027–2032
 Table 28. North America GLP-1 Weight Loss Pill Revenue by Country (US$ Million), 2021–2026
 Table 29. North America GLP-1 Weight Loss Pill Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe GLP-1 Weight Loss Pill Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe GLP-1 Weight Loss Pill Sales by Country (K Units), 2021–2026
 Table 32. Europe GLP-1 Weight Loss Pill Sales by Country (K Units), 2027–2032
 Table 33. Europe GLP-1 Weight Loss Pill Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe GLP-1 Weight Loss Pill Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific GLP-1 Weight Loss Pill Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific GLP-1 Weight Loss Pill Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific GLP-1 Weight Loss Pill Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific GLP-1 Weight Loss Pill Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific GLP-1 Weight Loss Pill Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America GLP-1 Weight Loss Pill Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America GLP-1 Weight Loss Pill Sales by Country (K Units), 2021–2026
 Table 42. Latin America GLP-1 Weight Loss Pill Sales by Country (K Units), 2027–2032
 Table 43. Latin America GLP-1 Weight Loss Pill Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America GLP-1 Weight Loss Pill Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa GLP-1 Weight Loss Pill Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa GLP-1 Weight Loss Pill Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa GLP-1 Weight Loss Pill Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa GLP-1 Weight Loss Pill Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa GLP-1 Weight Loss Pill Revenue by Country (US$ Million), 2027–2032
 Table 50. Global GLP-1 Weight Loss Pill Sales (K Units) by Type (2021–2026)
 Table 51. Global GLP-1 Weight Loss Pill Sales (K Units) by Type (2027–2032)
 Table 52. Global GLP-1 Weight Loss Pill Sales Market Share by Type (2021–2026)
 Table 53. Global GLP-1 Weight Loss Pill Sales Market Share by Type (2027–2032)
 Table 54. Global GLP-1 Weight Loss Pill Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global GLP-1 Weight Loss Pill Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global GLP-1 Weight Loss Pill Revenue Market Share by Type (2021–2026)
 Table 57. Global GLP-1 Weight Loss Pill Revenue Market Share by Type (2027–2032)
 Table 58. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Type (2021–2026)
 Table 59. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Type (2027–2032)
 Table 60. Global GLP-1 Weight Loss Pill Sales (K Units) by Application (2021–2026)
 Table 61. Global GLP-1 Weight Loss Pill Sales (K Units) by Application (2027–2032)
 Table 62. Global GLP-1 Weight Loss Pill Sales Market Share by Application (2021–2026)
 Table 63. Global GLP-1 Weight Loss Pill Sales Market Share by Application (2027–2032)
 Table 64. Global GLP-1 Weight Loss Pill Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global GLP-1 Weight Loss Pill Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global GLP-1 Weight Loss Pill Revenue Market Share by Application (2021–2026)
 Table 67. Global GLP-1 Weight Loss Pill Revenue Market Share by Application (2027–2032)
 Table 68. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Application (2021–2026)
 Table 69. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Application (2027–2032)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Novo Nordisk GLP-1 Weight Loss Pill Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Eli Lilly GLP-1 Weight Loss Pill Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. Reddy's Laboratories Company Information
 Table 81. Reddy's Laboratories Description and Business Overview
 Table 82. Reddy's Laboratories GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Reddy's Laboratories GLP-1 Weight Loss Pill Product
 Table 84. Reddy's Laboratories Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Merck GLP-1 Weight Loss Pill Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Aurisco Pharmaceuticals Company Information
 Table 91. Aurisco Pharmaceuticals Description and Business Overview
 Table 92. Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 94. Aurisco Pharmaceuticals Recent Developments/Updates
 Table 95. Huadong Medicine Company Information
 Table 96. Huadong Medicine Description and Business Overview
 Table 97. Huadong Medicine GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Huadong Medicine GLP-1 Weight Loss Pill Product
 Table 99. Huadong Medicine Recent Developments/Updates
 Table 100. Borui Pharmaceuticals Company Information
 Table 101. Borui Pharmaceuticals Description and Business Overview
 Table 102. Borui Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Borui Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 104. Borui Pharmaceuticals Recent Developments/Updates
 Table 105. Hengrui Medicine Company Information
 Table 106. Hengrui Medicine Description and Business Overview
 Table 107. Hengrui Medicine GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Hengrui Medicine GLP-1 Weight Loss Pill Product
 Table 109. Hengrui Medicine Recent Developments/Updates
 Table 110. Innovent Biologics Company Information
 Table 111. Innovent Biologics Description and Business Overview
 Table 112. Innovent Biologics GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Innovent Biologics GLP-1 Weight Loss Pill Product
 Table 114. Innovent Biologics Recent Developments/Updates
 Table 115. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
 Table 116. Shanghai Benemae Biopharmaceuticals Co., Ltd. Description and Business Overview
 Table 117. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Product
 Table 119. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments/Updates
 Table 120. Hansoh Pharmaceuticals Company Information
 Table 121. Hansoh Pharmaceuticals Description and Business Overview
 Table 122. Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 124. Hansoh Pharmaceuticals Recent Developments/Updates
 Table 125. Gan & Lee Pharmaceuticals Company Information
 Table 126. Gan & Lee Pharmaceuticals Description and Business Overview
 Table 127. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 129. Gan & Lee Pharmaceuticals Recent Developments/Updates
 Table 130. CSPC Pharmaceuticals Company Information
 Table 131. CSPC Pharmaceuticals Description and Business Overview
 Table 132. CSPC Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. CSPC Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 134. CSPC Pharmaceuticals Recent Developments/Updates
 Table 135. Wanbang Biopharma Company Information
 Table 136. Wanbang Biopharma Description and Business Overview
 Table 137. Wanbang Biopharma GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Wanbang Biopharma GLP-1 Weight Loss Pill Product
 Table 139. Wanbang Biopharma Recent Developments/Updates
 Table 140. Sihuan Pharmaceuticals Company Information
 Table 141. Sihuan Pharmaceuticals Description and Business Overview
 Table 142. Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Product
 Table 144. Sihuan Pharmaceuticals Recent Developments/Updates
 Table 145. Imeik Company Information
 Table 146. Imeik Description and Business Overview
 Table 147. Imeik GLP-1 Weight Loss Pill Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Imeik GLP-1 Weight Loss Pill Product
 Table 149. Imeik Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. GLP-1 Weight Loss Pill Distributors List
 Table 153. GLP-1 Weight Loss Pill Customers List
 Table 154. GLP-1 Weight Loss Pill Market Trends
 Table 155. GLP-1 Weight Loss Pill Market Drivers
 Table 156. GLP-1 Weight Loss Pill Market Challenges
 Table 157. GLP-1 Weight Loss Pill Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GLP-1 Weight Loss Pill
 Figure 2. Global GLP-1 Weight Loss Pill Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global GLP-1 Weight Loss Pill Market Share by Type: 2025 & 2032
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global GLP-1 Weight Loss Pill Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global GLP-1 Weight Loss Pill Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Pharmacy
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global GLP-1 Weight Loss Pill Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global GLP-1 Weight Loss Pill Market Size (US$ Million), 2021–2032
 Figure 14. Global GLP-1 Weight Loss Pill Sales (K Units), 2021–2032
 Figure 15. Global GLP-1 Weight Loss Pill Average Price (US$/Unit), 2021–2032
 Figure 16. GLP-1 Weight Loss Pill Report Years Considered
 Figure 17. GLP-1 Weight Loss Pill Sales Share by Manufacturers in 2025
 Figure 18. Global GLP-1 Weight Loss Pill Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global GLP-1 Weight Loss Pill Players: Market Share by Revenue in GLP-1 Weight Loss Pill in 2025
 Figure 20. GLP-1 Weight Loss Pill Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global GLP-1 Weight Loss Pill Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America GLP-1 Weight Loss Pill Sales Market Share by Country (2021–2032)
 Figure 23. North America GLP-1 Weight Loss Pill Revenue Market Share by Country (2021–2032)
 Figure 24. United States GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe GLP-1 Weight Loss Pill Sales Market Share by Country (2021–2032)
 Figure 27. Europe GLP-1 Weight Loss Pill Revenue Market Share by Country (2021–2032)
 Figure 28. Germany GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific GLP-1 Weight Loss Pill Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific GLP-1 Weight Loss Pill Revenue Market Share by Region (2021–2032)
 Figure 35. China GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America GLP-1 Weight Loss Pill Sales Market Share by Country (2021–2032)
 Figure 43. Latin America GLP-1 Weight Loss Pill Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa GLP-1 Weight Loss Pill Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa GLP-1 Weight Loss Pill Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE GLP-1 Weight Loss Pill Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of GLP-1 Weight Loss Pill by Type (2021–2032)
 Figure 54. Global Revenue Market Share of GLP-1 Weight Loss Pill by Type (2021–2032)
 Figure 55. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of GLP-1 Weight Loss Pill by Application (2021–2032)
 Figure 57. Global Revenue Market Share of GLP-1 Weight Loss Pill by Application (2021–2032)
 Figure 58. Global GLP-1 Weight Loss Pill Price (US$/Unit) by Application (2021–2032)
 Figure 59. GLP-1 Weight Loss Pill Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global GLP 1 Weight Loss Injection Market Research Report 2024
Global GLP 1 Weight Loss Drug Market Research Report 2024
GLP 1 for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024
Global GLP 1 Agonists for Obesity Market Research Report 2024
Global GLP 1RA based Therapy for Obesity Market Research Report 2024
Global Liraglutide for The Treatment of Diabetes and Obesity Market Research Report 2024
Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025
Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025
Global GLP 1 Receptor Agonist Drugs Market Research Report 2024
GLP Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025
Global GLP 1 based Therapy Market Research Report 2024
Global GLP 1 Drugs Market Research Report 2024
Global Oral GLP 1 Agonist Market Research Report 2024
Global GLP 1 Drug Peptide API Market Research Report 2024
Global GLP 1 Receptor Antagonist Market Research Report 2024
GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Injection Market Research Report 2024
Global GLP 1 Peptide Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions